{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:36:37Z","timestamp":1792272997474,"version":"4.4.0"},"reference-count":138,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH61019-02"],"award-info":[{"award-number":["R01 MH61019-02"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R21 MH086769"],"award-info":[{"award-number":["R21 MH086769"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA12382-01"],"award-info":[{"award-number":["R01 DA12382-01"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21 DA020750"],"award-info":[{"award-number":["R21 DA020750"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21 DA029826"],"award-info":[{"award-number":["R21 DA029826"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21 DA030696"],"award-info":[{"award-number":["R21 DA030696"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21 DA038821-01A1"],"award-info":[{"award-number":["R21 DA038821-01A1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.biopsych.2016.01.011","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T04:47:51Z","timestamp":1454388471000},"page":"526-538","source":"Crossref","is-referenced-by-count":124,"title":["Human Laboratory Studies on Cannabinoids and Psychosis"],"prefix":"10.1016","volume":"79","author":[{"given":"Mohamed","family":"Sherif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8220-655X","authenticated-orcid":false,"given":"Rajiv","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak Cyril","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohini","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2016.01.011_bib1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00213-011-2417-y","article-title":"The safety of studies with intravenous Delta(9)-tetrahydrocannabinol in humans, with case histories","volume":"219","author":"Carbuto","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2016.01.011_bib2","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis","volume":"29","author":"D\u2019Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2016.01.011_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hup.1166","article-title":"Synthetic delta-9-tetrahydrocannabinol elicits schizophrenia-like negative symptoms which are distinct from sedation","volume":"26","author":"Morrison","year":"2011","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib4","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1017\/S0033291709005522","article-title":"The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning","volume":"39","author":"Morrison","year":"2009","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2016.01.011_bib5","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1177\/0269881112446534","article-title":"Does olanzapine inhibit the psychomimetic effects of Delta9-tetrahydrocannabinol?","volume":"26","author":"Kleinloog","year":"2012","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib6","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1177\/0269881109358200","article-title":"Central nervous system effects of haloperidol on THC in healthy male volunteers","volume":"24","author":"Liem-Moolenaar","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00213-007-1042-2","article-title":"Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans","volume":"198","author":"D\u2019Souza","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2016.01.011_bib8","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/npp.2012.8","article-title":"Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Delta(9)-THC in humans","volume":"37","author":"D\u2019Souza","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2016.01.011_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.euroneuro.2014.11.018","article-title":"Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis","volume":"25","author":"Bhattacharyya","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/archgenpsychiatry.2011.161","article-title":"Induction of psychosis by Delta9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing","volume":"69","author":"Bhattacharyya","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archgenpsychiatry.2009.17","article-title":"Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: A neural basis for the effects of Cannabis sativa on learning and psychosis","volume":"66","author":"Bhattacharyya","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib12","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2016.01.011_bib13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/schbul\/sbu098","article-title":"How cannabis causes paranoia: Using the intravenous administration of 9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia","volume":"41","author":"Freeman","year":"2015","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2016.01.011_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0091-3057(00)00201-X","article-title":"Different effects of nabilone and cannabidiol on binocular depth inversion in Man","volume":"66","author":"Leweke","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2016.01.011_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s002130050884","article-title":"Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man","volume":"142","author":"Leweke","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2016.01.011_bib16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.schres.2006.07.023","article-title":"Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness","volume":"88","author":"Koethe","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2016.01.011_bib17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0091-3057(91)90383-D","article-title":"Reduced binocular depth inversion as an indicator of cannabis-induced censorship impairment","volume":"40","author":"Emrich","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2016.01.011_bib18","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archpsyc.62.9.985","article-title":"Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: Implications for glutamatergic and dopaminergic model psychoses and cognitive function","volume":"62","author":"Krystal","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib19","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.biopsych.2012.06.012","article-title":"Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the kappa opioid agonist salvinorin A in humans","volume":"72","author":"Ranganathan","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.schres.2015.01.033","article-title":"A systematic review of the antipsychotic properties of cannabidiol in humans","volume":"162","author":"Iseger","year":"2015","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2016.01.011_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0269881112460109","article-title":"Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment","volume":"27","author":"Englund","year":"2013","journal-title":"J Psychopharmacol."},{"key":"10.1016\/j.biopsych.2016.01.011_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archgenpsychiatry.2008.519","article-title":"Distinct effects of delta9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing","volume":"66","author":"Fusar-Poli","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00213-006-0508-y","article-title":"The acute effects of cannabinoids on memory in humans: A review","volume":"188","author":"Ranganathan","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2016.01.011_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0091-3057(77)90191-5","article-title":"Marijuana and memory impairment: Effect on free recall and recognition memory","volume":"7","author":"Miller","year":"1977","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2016.01.011_bib25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF00445566","article-title":"Divided attention performance in cannabis users and non-users following alcohol and cannabis separately and in combination","volume":"99","author":"Marks","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2016.01.011_bib26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000026487","article-title":"The effects of tetrahydrocannabinol on the recognition of emotionally charged words: An analysis using event-related brain potentials","volume":"37","author":"Leweke","year":"1998","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.biopsych.2016.01.011_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF00690920","article-title":"Increased susceptibility to memory intrusions and the Stroop interference effect during acute marijuana intoxication","volume":"91","author":"Hooker","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2016.01.011_bib28","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0893-133X(01)00273-1","article-title":"Effects of acute smoked marijuana on complex cognitive performance","volume":"25","author":"Hart","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2016.01.011_bib29","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0091-3057(90)90028-G","article-title":"Acute and residual effects of marijuana: Profiles of plasma THC levels, physiological, subjective, and performance measures","volume":"37","author":"Heishman","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2016.01.011_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1054\/plef.2001.0351","article-title":"Endocannabinoids in cognition and dependence","volume":"66","author":"Lichtman","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.biopsych.2016.01.011_bib31","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1063545","article-title":"Endocannabinoid signaling in the brain","volume":"296","author":"Wilson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2016.01.011_bib32","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.biopsych.2004.12.006","article-title":"Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction","volume":"57","author":"D\u2019Souza","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00213-008-1440-0","article-title":"Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC)","volume":"204","author":"Hunault","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2016.01.011_bib34","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1162\/jocn.2009.21355","article-title":"Cannabinoid modulations of resting state EEG theta power and working memory are correlated in humans","volume":"22","author":"Bocker","year":"2010","journal-title":"J Cogn Neurosci"},{"key":"10.1016\/j.biopsych.2016.01.011_bib35","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00213-004-1868-9","article-title":"Effects of marijuana on neurophysiological signals of working and episodic memory","volume":"176","author":"Ilan","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2016.01.011_bib36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00008877-200509000-00023","article-title":"Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids","volume":"16","author":"Ilan","year":"2005","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib37","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.npp.1301643","article-title":"Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis","volume":"33","author":"D\u2019Souza","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2016.01.011_bib38","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.pbb.2010.11.013","article-title":"Combined effects of acute, very-low-dose ethanol and delta(9)-tetrahydrocannabinol in healthy human volunteers","volume":"97","author":"Ballard","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2016.01.011_bib39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00213-002-1169-0","article-title":"Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users","volume":"164","author":"Curran","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2016.01.011_bib40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpsycho.2005.12.012","article-title":"Neuropsychology and neuropharmacology of P3a and P3b","volume":"60","author":"Polich","year":"2006","journal-title":"Int J Psychophysiol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/schbul\/sbl060","article-title":"Neurophysiological endophenotypes of schizophrenia: The viability of selected candidate measures","volume":"33","author":"Turetsky","year":"2007","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2016.01.011_bib42","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/1469-8986.00070","article-title":"Meta-analysis of P300 and schizophrenia: Patients, paradigms, and practical implications","volume":"40","author":"Jeon","year":"2003","journal-title":"Psychophysiology"},{"key":"10.1016\/j.biopsych.2016.01.011_bib43","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.neuroimage.2005.05.022","article-title":"Is the P300 wave an endophenotype for schizophrenia? A meta-analysis and a family study","volume":"27","author":"Bramon","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2016.01.011_bib44","first-page":"30","article-title":"Cannabis and cognitive dysfunction: Parallels with endophenotypes of schizophrenia?","volume":"32","author":"Solowij","year":"2007","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.biopsych.2016.01.011_bib45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.schres.2004.01.004","article-title":"Meta-analysis of the P300 and P50 waveforms in schizophrenia","volume":"70","author":"Bramon","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2016.01.011_bib46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.euroneuro.2008.04.008","article-title":"Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers","volume":"18","author":"Roser","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF01195257","article-title":"Generators of electrical and magnetic mismatch responses in humans","volume":"7","author":"Naatanen","year":"1995","journal-title":"Brain Topogr"},{"key":"10.1016\/j.biopsych.2016.01.011_bib48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1006\/nimg.2000.0591","article-title":"Separate time behaviors of the temporal and frontal mismatch negativity sources","volume":"12","author":"Rinne","year":"2000","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2016.01.011_bib49","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.biopsych.2013.07.038","article-title":"Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: Forecasting psychosis risk with mismatch negativity","volume":"75","author":"Perez","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib50","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00213-012-2676-2","article-title":"Delayed preattentional functioning in early psychosis patients with cannabis use","volume":"222","author":"Pesa","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2016.01.011_bib51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.schres.2007.08.015","article-title":"Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity","volume":"97","author":"Juckel","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2016.01.011_bib52","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.expneurol.2007.02.004","article-title":"Differential impact of heavy cannabis use on sensory gating in schizophrenic patients and otherwise healthy controls","volume":"205","author":"Rentzsch","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib53","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.schres.2007.04.028","article-title":"A meta-analysis of P50 studies in patients with schizophrenia and relatives: Differences in methodology between research groups","volume":"97","author":"de Wilde","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2016.01.011_bib54","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.psychres.2007.02.009","article-title":"P50 sensory gating ratios in schizophrenics and controls: A review and data analysis","volume":"158","author":"Patterson","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2016.01.011_bib55","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0006-3223(98)00155-3","article-title":"Reduced P50 auditory gating response in psychiatrically normal chronic marihuana users: A pilot study","volume":"45","author":"Patrick","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib56","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/155005940003100207","article-title":"Reduction of auditory P50 gating response in marihuana users: Further supporting data","volume":"31","author":"Patrick","year":"2000","journal-title":"Clin Electroencephalogr"},{"key":"10.1016\/j.biopsych.2016.01.011_bib57","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tics.2009.12.002","article-title":"Neural synchrony and the development of cortical networks","volume":"14","author":"Uhlhaas","year":"2010","journal-title":"Trends Cogn Sci"},{"key":"10.1016\/j.biopsych.2016.01.011_bib58","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrn2774","article-title":"Abnormal neural oscillations and synchrony in schizophrenia","volume":"11","author":"Uhlhaas","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2016.01.011_bib59","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/schbul\/sbn062","article-title":"The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia","volume":"34","author":"Uhlhaas","year":"2008","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2016.01.011_bib60","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1046\/j.1460-9568.2000.00217.x","article-title":"Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations","volume":"12","author":"Hajos","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2016.01.011_bib61","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.biopsych.2007.12.005","article-title":"Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: Relevance to schizophrenia","volume":"63","author":"Hajos","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib62","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1073\/pnas.1217144110","article-title":"Striatal GABAergic and cortical glutamatergic neurons mediate contrasting effects of cannabinoids on cortical network synchrony","volume":"110","author":"Sales-Carbonell","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2016.01.011_bib63","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/npp.2015.53","article-title":"Delta(9)-THC disrupts gamma (gamma)-band neural oscillations in humans","volume":"40","author":"Cortes-Briones","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2016.01.011_bib64","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/npp.2010.222","article-title":"Disruption of frontal theta coherence by Delta9-tetrahydrocannabinol is associated with positive psychotic symptoms","volume":"36","author":"Morrison","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2016.01.011_bib65","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clinph.2005.09.024","article-title":"The effect of cannabis use and gender on the visual steady state evoked potential","volume":"117","author":"Skosnik","year":"2006","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib66","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1037\/a0016328","article-title":"Sensory gating impairments in heavy cannabis users are associated with altered neural oscillations","volume":"123","author":"Edwards","year":"2009","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.biopsych.2016.01.011_bib67","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1038\/npp.2012.65","article-title":"The effect of chronic cannabinoids on broadband EEG neural oscillations in humans","volume":"37","author":"Skosnik","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2016.01.011_bib68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1566-2772(03)00019-7","article-title":"Cortical signal-to-noise ratio: Insight into the pathophysiology and genetics of schizophrenia","volume":"3","author":"Winterer","year":"2003","journal-title":"Clin Neurosci Res"},{"key":"10.1016\/j.biopsych.2016.01.011_bib69","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1176\/appi.ajp.161.3.490","article-title":"Prefrontal broadband noise, working memory, and genetic risk for schizophrenia","volume":"161","author":"Winterer","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib70","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1073\/pnas.1405289111","article-title":"Altered global brain signal in schizophrenia","volume":"111","author":"Yang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2016.01.011_bib71","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.biopsych.2015.03.023","article-title":"The psychosis-like effects of delta-tetrahydrocannabinol are associated with increased cortical noise in healthy humans","volume":"78","author":"Cortes-Briones","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib72","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/aje\/kwf043","article-title":"Cannabis use and psychosis: A longitudinal population-based study","volume":"156","author":"van Os","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/bmj.38267.664086.63","article-title":"Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people","volume":"330","author":"Henquet","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.biopsych.2016.01.011_bib74","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1038\/sj.npp.1301197","article-title":"An experimental study of catechol-O-methyltransferase Val(158)Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition","volume":"31","author":"Henquet","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2016.01.011_bib75","doi-asserted-by":"crossref","first-page":"8709","DOI":"10.1523\/JNEUROSCI.2077-08.2008","article-title":"Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice","volume":"28","author":"Papaleo","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2016.01.011_bib76","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.psychres.2009.08.022","article-title":"Catechol-O-methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: clinical-onset implications","volume":"179","author":"Pelayo-Teran","year":"2010","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2016.01.011_bib77","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.biopsych.2005.01.026","article-title":"Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction","volume":"57","author":"Caspi","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib78","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11126-009-9108-4","article-title":"Adolescent cannabis use, psychosis and catechol-O-methyltransferase genotype in African Americans and Caucasians","volume":"80","author":"Kantrowitz","year":"2009","journal-title":"Psychiatr Q"},{"key":"10.1016\/j.biopsych.2016.01.011_bib79","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1192\/bjp.bp.107.036129","article-title":"Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: Interactions with tobacco and cannabis use","volume":"191","author":"Zammit","year":"2007","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib80","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/hmg\/ddm347","article-title":"A network of dopaminergic gene variations implicated as risk factors for schizophrenia","volume":"17","author":"Talkowski","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biopsych.2016.01.011_bib81","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/mp.2011.187","article-title":"Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of delta-9-tetrahydrocannabinol on midbrain and striatal function","volume":"17","author":"Bhattacharyya","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib82","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.biopsych.2007.06.005","article-title":"AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families","volume":"63","author":"Thiselton","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib83","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng1296","article-title":"Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia","volume":"36","author":"Emamian","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2016.01.011_bib84","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/archgenpsychiatry.2010.152","article-title":"Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: Sibling analysis and proband follow-up","volume":"68","author":"van Winkel","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib85","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.biopsych.2012.06.020","article-title":"Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users","volume":"72","author":"Di Forti","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib86","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1038\/npp.2011.141","article-title":"AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder","volume":"36","author":"van Winkel","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2016.01.011_bib87","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00213-007-0721-3","article-title":"Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol","volume":"192","author":"Boucher","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2016.01.011_bib88","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ajmg.b.31174","article-title":"Age at onset of psychotic disorder: Cannabis, BDNF Val66Met, and sex-specific models of gene-environment interaction","volume":"156B","author":"Decoster","year":"2011","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.biopsych.2016.01.011_bib89","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.schres.2011.02.021","article-title":"Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia","volume":"128","author":"Ho","year":"2011","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2016.01.011_bib90","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuroimage.2009.06.029","article-title":"Can recreational doses of THC produce significant dopamine release in the human striatum?","volume":"48","author":"Stokes","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2016.01.011_bib91","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1177\/0269881110382465","article-title":"Does intravenous Delta9-tetrahydrocannabinol increase dopamine release? A SPET study","volume":"25","author":"Barkus","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib92","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/npp.2008.138","article-title":"Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum","volume":"34","author":"Bossong","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2016.01.011_bib93","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/s00213-015-3915-0","article-title":"Further human evidence for striatal dopamine release induced by administration of 9-tetrahydrocannabinol (THC): Selectivity to limbic striatum","volume":"232","author":"Bossong","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2016.01.011_bib94","first-page":"e70378","article-title":"Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study","volume":"8","author":"Kuepper","year":"2013"},{"key":"10.1016\/j.biopsych.2016.01.011_bib95","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1523\/JNEUROSCI.17-14-05327.1997","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: Evidence for a Gs linkage to the CB1 receptor","volume":"17","author":"Glass","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2016.01.011_bib96","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/syn.21796","article-title":"Cannabinoid CB1 receptors activation and coactivation with D2 receptors modulate GABAergic neurotransmission in the globus pallidus and increase motor asymmetry","volume":"69","author":"Munoz-Arenas","year":"2015","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2016.01.011_bib97","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pnpbp.2011.12.004","article-title":"Cannabinoid modulation of the dopaminergic circuitry: Implications for limbic and striatal output","volume":"38","author":"Fitzgerald","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib98","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.drugalcdep.2013.02.028","article-title":"Gamma-amino butyric acid and glutamate abnormalities in adolescent chronic marijuana smokers","volume":"129","author":"Prescot","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2016.01.011_bib99","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2183\/pjab.90.235","article-title":"Control of synaptic function by endocannabinoid-mediated retrograde signaling","volume":"90","author":"Kano","year":"2014","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"10.1016\/j.biopsych.2016.01.011_bib100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2010.04.029","article-title":"Modulation of NMDA and AMPA-mediated synaptic transmission by CB1 receptors in frontal cortical pyramidal cells","volume":"1342","author":"Li","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2016.01.011_bib101","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.neuropharm.2011.01.039","article-title":"Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: Implications for endocannabinoid control of hippocampal neural plasticity","volume":"60","author":"Hampson","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2016.01.011_bib102","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/schbul\/sbs010","article-title":"NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia","volume":"38","author":"Gonzalez-Burgos","year":"2012","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2016.01.011_bib103","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1089\/ars.2012.5100","article-title":"Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate","volume":"19","author":"Sanchez-Blazquez","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.biopsych.2016.01.011_bib104","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1756-6606-6-42","article-title":"HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity","volume":"6","author":"Vicente-Sanchez","year":"2013","journal-title":"Mol Brain"},{"key":"10.1016\/j.biopsych.2016.01.011_bib105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fphar.2013.00169","article-title":"The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: Implications in psychosis and schizophrenia","volume":"4","author":"Sanchez-Blazquez","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib106","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/npp.2015.58","article-title":"GABA deficits enhance the psychotomimetic effects of delta(9)-THC","volume":"40","author":"Radhakrishnan","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2016.01.011_bib107","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.neuroscience.2010.06.011","article-title":"Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex","volume":"169","author":"Eggan","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2016.01.011_bib108","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1113\/jphysiol.2011.226175","article-title":"Functional characteristics of parvalbumin- and cholecystokinin-expressing basket cells","volume":"590","author":"Bartos","year":"2012","journal-title":"J Physiol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib109","doi-asserted-by":"crossref","first-page":"9782","DOI":"10.1523\/JNEUROSCI.3269-05.2005","article-title":"Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillations","volume":"25","author":"Klausberger","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2016.01.011_bib110","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1210\/en.2010-0638","article-title":"Retrograde endocannabinoid signaling reduces GABAergic synaptic transmission to gonadotropin-releasing hormone neurons","volume":"151","author":"Farkas","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopsych.2016.01.011_bib111","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1113\/jphysiol.2011.224659","article-title":"Cortical basket cell dysfunction in schizophrenia","volume":"590","author":"Curley","year":"2012","journal-title":"J Physiol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib112","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2016.01.011_bib113","article-title":"The role of endocannabinoid signaling in cortical inhibitory neuron dysfunction in schizophrenia [published online ahead of print Jun 19]","author":"Volk","year":"2015","journal-title":"Biol Psychiatry."},{"key":"10.1016\/j.biopsych.2016.01.011_bib114","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.neuron.2014.10.018","article-title":"Computational psychiatry","volume":"84","author":"Wang","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2016.01.011_bib115","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1152\/jn.1968.31.6.884","article-title":"Theoretical reconstruction of field potentials and dendrodendritic synaptic interactions in olfactory bulb","volume":"31","author":"Rall","year":"1968","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib116","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1152\/jn.1991.66.3.1059","article-title":"Simulations of cortical pyramidal neurons synchronized by inhibitory interneurons","volume":"66","author":"Lytton","year":"1991","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib117","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00213-015-4143-3","article-title":"The early identification of psychosis: Can lessons be learnt from cardiac stress testing?","volume":"233","author":"Gupta","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2016.01.011_bib118","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/0269881108089581","article-title":"Effect of intrapulmonary tetrahydrocannabinol administration in humans","volume":"22","author":"Zuurman","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib119","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.biopsych.2012.01.008","article-title":"Effects of delta9-tetrahydrocannabinol on human working memory function","volume":"71","author":"Bossong","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib120","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1162\/jocn_a_00156","article-title":"Effects of Delta9-tetrahydrocannabinol administration on human encoding and recall memory function: A pharmacological FMRI study","volume":"24","author":"Bossong","year":"2012","journal-title":"J Cogn Neurosci"},{"key":"10.1016\/j.biopsych.2016.01.011_bib121","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.neuroimage.2012.07.051","article-title":"Manipulating brain connectivity with delta(9)-tetrahydrocannabinol: A pharmacological resting state FMRI study","volume":"63","author":"Klumpers","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2016.01.011_bib122","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/bcp.12141","article-title":"Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects","volume":"76","author":"Klumpers","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib123","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/bcp.12071","article-title":"Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Delta9-tetrahydrocannabinol-induced central nervous system and heart rate effects in humans","volume":"76","author":"Klumpers","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib124","doi-asserted-by":"crossref","first-page":"e70074","DOI":"10.1371\/journal.pone.0070074","article-title":"Default mode network in the effects of delta9-tetrahydrocannabinol (THC) on human executive function","volume":"8","author":"Bossong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2016.01.011_bib125","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.euroneuro.2013.06.009","article-title":"The endocannabinoid system and emotional processing: A pharmacological fMRI study with 9-tetrahydrocannabinol","volume":"23","author":"Bossong","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib126","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1038\/tp.2013.6","article-title":"THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction","volume":"3","author":"Jansma","year":"2013","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib127","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1089\/brain.2014.0314","article-title":"Subjective effects of ethanol, morphine, delta-tetrahydrocannabinol, and ketamine following a pharmacological challenge are related to functional brain connectivity","volume":"5","author":"Kleinloog","year":"2015","journal-title":"Brain Connect"},{"key":"10.1016\/j.biopsych.2016.01.011_bib128","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.biopsych.2008.05.011","article-title":"Neural basis of delta-9-tetrahydrocannabinol and cannabidiol: Effects during response inhibition","volume":"64","author":"Borgwardt","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib129","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S1461145709990617","article-title":"Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol","volume":"13","author":"Fusar-Poli","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1590\/S1516-44462010000100011","article-title":"Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD)","volume":"32","author":"Hallak","year":"2010","journal-title":"Rev Bras Psiquiatr"},{"key":"10.1016\/j.biopsych.2016.01.011_bib131","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/npp.2011.17","article-title":"Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: An FMRI study","volume":"36","author":"Winton-Brown","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2016.01.011_bib132","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1017\/S1461145711001830","article-title":"Naltrexone does not attenuate the effects of intravenous Delta9-tetrahydrocannabinol in healthy humans","volume":"15","author":"Ranganathan","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2016.01.011_bib133","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1017\/S0033291712001924","article-title":"Cannabis affects people differently: Inter-subject variation in the psychotogenic effects of Delta9-tetrahydrocannabinol: A functional magnetic resonance imaging study with healthy volunteers","volume":"43","author":"Atakan","year":"2013","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2016.01.011_bib134","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00213-014-3684-1","article-title":"Delta-9-tetrahydrocannabinol, neural oscillations above 20 Hz and induced acute psychosis","volume":"232","author":"Nottage","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2016.01.011_bib135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1055\/s-0029-1237397","article-title":"Acute psychotropic effects of oral cannabis extract with a defined content of Delta9-tetrahydrocannabinol (THC) in healthy volunteers","volume":"43","author":"Kaufmann","year":"2010","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib136","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archpsyc.1972.01750300071012","article-title":"Contingent negative variation amplitudes. Marihuana and alcohol","volume":"27","author":"Kopell","year":"1972","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2016.01.011_bib137","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neulet.2011.04.003","article-title":"Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential","volume":"496","author":"Stadelmann","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2016.01.011_bib138","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/npp.2014.258","article-title":"Cannabinoid modulation of functional connectivity within regions processing attentional salience","volume":"40","author":"Bhattacharyya","year":"2015","journal-title":"Neuropsychopharmacology"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322316000822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322316000822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T05:13:53Z","timestamp":1617340433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322316000822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":138,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0006322316000822"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2016.01.011","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}